These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 6114428

  • 1. Disorders of neuromuscular transmission other than myasthenia gravis.
    Swift TR.
    Muscle Nerve; 1981; 4(4):334-53. PubMed ID: 6114428
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The pharmacological basis for the treatment of myasthenia gravis.
    Flacke W.
    Pharmacol Physicians; 1970 Jun; 4(6):1-7. PubMed ID: 4316342
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
    Simpson JA.
    Muscle Nerve; 1978 Jun; 1(2):151-6. PubMed ID: 220530
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI, Goldner MM, Sanders DB.
    Muscle Nerve; 1980 Jun; 3(2):112-9. PubMed ID: 6245355
    [Abstract] [Full Text] [Related]

  • 9. [Neuromuscular disorders, especially myasthenia].
    Loyning Y.
    Tidsskr Nor Laegeforen; 1972 Apr 30; 92(12):855-8. PubMed ID: 4337652
    [No Abstract] [Full Text] [Related]

  • 10. Disorders of neuromuscular transmission: a review.
    Daube JR.
    Arch Phys Med Rehabil; 1983 May 30; 64(5):195-200. PubMed ID: 6303269
    [Abstract] [Full Text] [Related]

  • 11. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B, Phillips LH, Juel VC.
    Semin Neurol; 2008 Apr 30; 28(2):212-27. PubMed ID: 18351523
    [Abstract] [Full Text] [Related]

  • 12. [Diseases of the motoric end plate including myasthenia gravis].
    Struppler A.
    Wien Klin Wochenschr; 1967 Aug 18; 79(33):620-2. PubMed ID: 4298887
    [No Abstract] [Full Text] [Related]

  • 13. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW.
    Muscle Nerve; 1982 Aug 18; 5(9S):S12-6. PubMed ID: 6302487
    [Abstract] [Full Text] [Related]

  • 14. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
    Kim YI.
    Muscle Nerve; 1985 Feb 18; 8(2):162-72. PubMed ID: 2997605
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles.
    Serra A, Ruff R, Kaminski H, Leigh RJ.
    Ann N Y Acad Sci; 2011 Sep 18; 1233():26-33. PubMed ID: 21950972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The pathophysiology of some disorders of neuromuscular transmission].
    Elmqvist D.
    Tidsskr Nor Laegeforen; 1971 Apr 20; 91(11):816-9. PubMed ID: 5089803
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.